OASGX
Price
$11.95
Change
-$0.02 (-0.17%)
Updated
Aug 15 closing price
Net Assets
724.08M
VEXRX
Price
$108.24
Change
-$0.15 (-0.14%)
Updated
Aug 15 closing price
Net Assets
19.88B
Interact to see
Advertisement

OASGX vs VEXRX

Header iconOASGX vs VEXRX Comparison
Open Charts OASGX vs VEXRXBanner chart's image
Optimum Small-Mid Cap Growth A
Price$11.95
Change-$0.02 (-0.17%)
VolumeN/A
Net Assets724.08M
Vanguard Explorer Adm
Price$108.24
Change-$0.15 (-0.14%)
VolumeN/A
Net Assets19.88B
OASGX vs VEXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OASGX vs. VEXRX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OASGX is a Buy and VEXRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.9B vs. OASGX (724M). VEXRX pays higher dividends than OASGX: VEXRX (0.52) vs OASGX (0.00). OASGX was incepted earlier than VEXRX: OASGX (22 years) vs VEXRX (24 years). OASGX (1.66) is less costly to investors than VEXRX (0.33). OASGX is a more actively managed with annual turnover of: 131.00 vs. VEXRX (35.00). OASGX has a lower initial minimum investment than VEXRX: OASGX (1000) vs VEXRX (50000). OASGX annual gain was more profitable for investors over the last year : 5.85 vs. VEXRX (-1.41). VEXRX return over 5 years is better than : 5.54 vs. OASGX (-21.74).
OASGXVEXRXOASGX / VEXRX
Total Expense Ratio1.490.33452%
Annual Report Gross Expense Ratio1.660.33503%
Fund Existence22 years24 years-
Gain YTD1.7021.301131%
Front Load6%N/A-
Min. Initial Investment1000500002%
Min. Initial Investment IRAN/AN/A-
Net Assets724M19.9B4%
Annual Yield % from dividends0.000.52-
Returns for 1 year5.85-1.41-414%
Returns for 3 years2.935.9050%
Returns for 5 years-21.745.54-392%
Returns for 10 years-21.7420.49-106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXRX1.240.06
+5.08%
Lexicon Pharmaceuticals
ISRL12.700.39
+3.17%
Israel Acquisitions Corp
MESO16.250.39
+2.46%
Mesoblast Limited
SXTP1.320.01
+0.76%
60 Degrees Pharmaceuticals Inc.
EHC120.380.73
+0.61%
Encompass Health Corp